We previously reported profound population-level health effects of this care delivery model among HIV-infected persons, including reduced mortality among those with prevalent HIV infection [17] and men with low CD4 counts [30], improved viral suppression among those with HIV viremia despite prior attempts at care engagement [31], reduced maternal-to-child transmission of HIV [32], and decreased incidence of tuberculosis [17]. The gene discussed is CD4; the disease is tuberculosis.